Search research articles
Contact Us
Filters
Showing results (31-40 of 123) with videos related to
Page
of 13
Sort By:
Cancer Treatment Reviews
|
February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
Giannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.
Cancer Research
|
March 15, 2014
Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy
Reza Mehran, Monique Nilsson, Mehrdad Khajavi, et al.
Journal of Cellular Physiology
|
May 12, 2006
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases
Maria Pia Morelli, Tina Cascone, Teresa Troiani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 26, 2021
Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC
Sonia A Patel, Matthew H Herynk, Tina Cascone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations
Kelsey Pan, Jennifer Owens, Yasir Elamin, et al.
The Journal of Biological Chemistry
|
September 5, 2021
Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers
Jayanthi P Gudikote, Tina Cascone, Alissa Poteete, et al.
Clinical Lung Cancer
|
April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Annikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Sonia A Patel, Monique B Nilsson, Yan Yang, et al.
The Annals of Thoracic Surgery
|
December 9, 2017
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
Tina Cascone, Kathryn A Gold, Stephen G Swisher, et al.
The Annals of Thoracic Surgery
|
September 25, 2019
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer
Kyle G Mitchell, Marcelo V Negrao, Edwin R Parra, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 123) with videos related to
Sort By:
Page
of 13
Cancer Treatment Reviews
|
February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
Giannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.
Cancer Research
|
March 15, 2014
Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy
Reza Mehran, Monique Nilsson, Mehrdad Khajavi, et al.
Journal of Cellular Physiology
|
May 12, 2006
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases
Maria Pia Morelli, Tina Cascone, Teresa Troiani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 26, 2021
Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC
Sonia A Patel, Matthew H Herynk, Tina Cascone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations
Kelsey Pan, Jennifer Owens, Yasir Elamin, et al.
The Journal of Biological Chemistry
|
September 5, 2021
Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers
Jayanthi P Gudikote, Tina Cascone, Alissa Poteete, et al.
Clinical Lung Cancer
|
April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
Annikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Sonia A Patel, Monique B Nilsson, Yan Yang, et al.
The Annals of Thoracic Surgery
|
December 9, 2017
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
Tina Cascone, Kathryn A Gold, Stephen G Swisher, et al.
The Annals of Thoracic Surgery
|
September 25, 2019
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer
Kyle G Mitchell, Marcelo V Negrao, Edwin R Parra, et al.
Page
of 13